Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 2004; Volume 310,Issue 2

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Genetic Polymorphisms in Human Proton-Dependent Dipeptide Transporter PEPT1: Implications for the Functional Role of Pro586
    Eric Y. Zhang, Dong-Jing Fu, Youngeen A. Pak, Trent Stewart, Nitai Mukhopadhyay, Steven A. Wrighton and Kathleen M. Hillgren
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 437-445; DOI: https://doi.org/10.1124/jpet.104.065912
  • You have access
    Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1
    Zejin Sun, Daryl J. Murry, Sonal P. Sanghani, Wilhelmina I. Davis, Natalia Y. Kedishvili, Qin Zou, Thomas D. Hurley and William F. Bosron
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 469-476; DOI: https://doi.org/10.1124/jpet.104.067116
  • You have access
    Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor
    Dan E. Brobst, Xunshan Ding, Katrina L. Creech, Bryan Goodwin, Brian Kelley and Jeff L. Staudinger
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 528-535; DOI: https://doi.org/10.1124/jpet.103.064329
  • You have access
    Metabolism of Thalidomide in Liver Microsomes of Mice, Rabbits, and Humans
    Jun Lu, Nuala Helsby, Brian D. Palmer, Malcolm Tingle, Bruce C. Baguley, Philip Kestell and Lai-Ming Ching
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 571-577; DOI: https://doi.org/10.1124/jpet.104.067793
  • You have access
    Abolition of Valproate-Derived Choleresis in the Mrp2 Transporter-Deficient Rat
    Andrew W. E. Wright and Ronald G. Dickinson
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 584-588; DOI: https://doi.org/10.1124/jpet.103.064220
  • You have access
    Differential Involvement of Multidrug Resistance-Associated Protein 1 and P-Glycoprotein in Tissue Distribution and Excretion of Grepafloxacin in Mice
    Hiroyuki Sasabe, Yukio Kato, Takashi Suzuki, Minoru Itose, Gohachiro Miyamoto and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 648-655; DOI: https://doi.org/10.1124/jpet.104.065201
  • You have access
    UDP-Glucuronosyltransferase (UGT) 2B15 Pharmacogenetics: UGT2B15 D85Y Genotype and Gender Are Major Determinants of Oxazepam Glucuronidation by Human Liver
    Michael H. Court, Qin Hao, Soundararajan Krishnaswamy, Tanios Bekaii-Saab, Abdul Al-Rohaimi, Lisa L. von Moltke and David J. Greenblatt
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 656-665; DOI: https://doi.org/10.1124/jpet.104.067660
  • You have access
    Preclinical Pharmacokinetic Properties of the P-Glycoprotein Inhibitor GF120918A (HCl salt of GF120918, 9,10-Dihydro-5-methoxy-9-oxo-N-[4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl]-4-acridine-carboxamide) in the Mouse, Rat, Dog, and Monkey
    Keith W. Ward and Leonard M. Azzarano
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 703-709; DOI: https://doi.org/10.1124/jpet.104.068288
  • You have access
    Hepatic Disposition and Effects of Nitric Oxide Donors: Rapid and Concentration-Dependent Reduction in the Cytochrome P450-Mediated Drug Metabolism in Isolated Perfused Rat Livers
    Ragini Vuppugalla and Reza Mehvar
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 718-727; DOI: https://doi.org/10.1124/jpet.104.065557
  • You have access
    Unique Properties of a Renal Sulfotransferase, St1d1, in Dopamine Metabolism
    Miki Shimada, Reiko Terazawa, Yoshiteru Kamiyama, Wataru Honma, Kiyoshi Nagata and Yasushi Yamazoe
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 808-814; DOI: https://doi.org/10.1124/jpet.104.065532

CARDIOVASCULAR

  • You have access
    Imidazoline Receptors but Not α2-Adrenoceptors Are Regulated in Spontaneously Hypertensive Rat Heart by Chronic Moxonidine Treatment
    Rouwayda El-Ayoubi, Ahmed Menaouar, Jolanta Gutkowska and Suhayla Mukaddam-Daher
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 446-451; DOI: https://doi.org/10.1124/jpet.104.067595
  • You have access
    Poly(ADP-Ribose) Polymerase Contributes to the Development of Myocardial Infarction in Diabetic Rats and Regulates the Nuclear Translocation of Apoptosis-Inducing Factor
    Chun-Yang Xiao, Min Chen, Zsuzsanna Zsengellér and Csaba Szabó
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 498-504; DOI: https://doi.org/10.1124/jpet.104.066803
  • You have access
    The Nitric Oxide-Releasing Naproxen Derivative Displays Cardioprotection in Perfused Rabbit Heart Submitted to Ischemia-Reperfusion
    Giuseppe Rossoni, Barbara Manfredi, Piero Del Soldato and Ferruccio Berti
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 555-562; DOI: https://doi.org/10.1124/jpet.104.067397
  • You have access
    Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome
    Lin Wu, John C. Shryock, Yejia Song, Yuan Li, Charles Antzelevitch and Luiz Belardinelli
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 599-605; DOI: https://doi.org/10.1124/jpet.104.066100
  • You have access
    Effects of Heat Shock Protein 70 Activation by Metabolic Inhibition Preconditioning or κ-Opioid Receptor Stimulation on Ca2+ Homeostasis in Rat Ventricular Myocytes Subjected to Ischemic Insults
    Jing Liu, Kenneth W. L. Kam, Jing-Jun Zhou, Wing-Yi Yan, Mai Chen, Song Wu and Tak Ming Wong
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 606-613; DOI: https://doi.org/10.1124/jpet.104.067926
  • You have access
    Diminished Inotropic Response to Amrinone in Ventricular Myocytes from Myopathic Hamsters Is Linked to Depression of High-Gain Ca2+-Induced Ca2+ Release
    Wei Xiong, Gregory R. Ferrier and Susan E. Howlett
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 761-773; DOI: https://doi.org/10.1124/jpet.103.064873

CELLULAR AND MOLECULAR

  • You have access
    Generation and Characterization of a Human Bradykinin Receptor B1 Transgenic Rat as a Pharmacodynamic Model
    J. Fred Hess, Richard W. Ransom, Zhizhen Zeng, Raymond S. L. Chang, Patricia J. Hey, Lee Warren, Charles M. Harrell, Kathryn L. Murphy, Tsing-Bau Chen, Patricia J. Miller, Edward Lis, Duane Reiss, Raymond E. Gibson, M. Kristine Markowitz, Robert M. DiPardo, Dai-Shi Su, Mark G. Bock, Robert J. Gould and Douglas J. Pettibone
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 488-497; DOI: https://doi.org/10.1124/jpet.104.066886
  • You have access
    Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A
    Jeremiah Gates, Shawn M. Ferguson, Randy D. Blakely and Subbu Apparsundaram
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 536-545; DOI: https://doi.org/10.1124/jpet.104.066795
  • You have access
    Metallothionein Mediates the Level and Activity of Nuclear Factor ΚB in Murine Fibroblasts
    Heather L. Butcher, Wendy A. Kennette, Olga Collins, Rudolfs K. Zalups and James Koropatnick
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 589-598; DOI: https://doi.org/10.1124/jpet.104.066126
  • You have access
    Different Regulation of Human δ-Opioid Receptors by SNC-80 [(+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and Endogenous Enkephalins
    I. Lecoq, N. Marie, Ph. Jauzac and S. Allouche
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 666-677; DOI: https://doi.org/10.1124/jpet.103.063958
  • You have access
    A Rapid in Vitro Screening for Delivery of Peptide-Derived Peptidase Inhibitors as Potential Drug Candidates via Epithelial Peptide Transporters
    Martin Foltz, Antje Meyer, Stephan Theis, Hans-Ulrich Demuth and Hannelore Daniel
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 695-702; DOI: https://doi.org/10.1124/jpet.104.066480
  • You have access
    Acetoacetate Activation of Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase in Primary Cultured Rat Hepatocytes: Role of Oxidative Stress
    Mohamed A. Abdelmegeed, Sang K. Kim, Kimberley J. Woodcroft and Raymond F. Novak
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 728-736; DOI: https://doi.org/10.1124/jpet.104.066522
  • You have access
    Nonsteroidal Anti-Inflammatory Drugs Potentiate 1-Methyl-4-phenylpyridinium (MPP+)-Induced Cell Death by Promoting the Intracellular Accumulation of MPP+ in PC12 Cells
    Norimitsu Morioka, Kei Kumagai, Katsuya Morita, Shigeo Kitayama and Toshihiro Dohi
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 800-807; DOI: https://doi.org/10.1124/jpet.104.065300

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Intratumoral NAMI-A Treatment Triggers Metastasis Reduction, Which Correlates to CD44 Regulation and Tumor Infiltrating Lymphocyte Recruitment
    Sabrina Pacor, Sonia Zorzet, Moreno Cocchietto, Marina Bacac, Marta Vadori, Claudia Turrin, Barbara Gava, Anna Castellarin and Gianni Sava
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 737-744; DOI: https://doi.org/10.1124/jpet.104.066175
  • You have access
    ABCG2 Mediates Differential Resistance to SN-38 (7-Ethyl-10-hydroxycamptothecin) and Homocamptothecins
    Susan E. Bates, Wilma Y. Medina-Pérez, Glenda Kohlhagen, Smitha Antony, Tim Nadjem, Robert W. Robey and Yves Pommier
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 836-842; DOI: https://doi.org/10.1124/jpet.103.063149

ENDOCRINE AND REPRODUCTIVE

  • You have access
    Metformin Causes Reduction of Food Intake and Body Weight Gain and Improvement of Glucose Intolerance in Combination with Dipeptidyl Peptidase IV Inhibitor in Zucker fa/fa Rats
    Nobuyuki Yasuda, Takashi Inoue, Tadashi Nagakura, Kazuto Yamazaki, Kazunobu Kira, Takao Saeki and Isao Tanaka
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 614-619; DOI: https://doi.org/10.1124/jpet.103.064964

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Rapid Up-Regulation of Endothelial Nitric-Oxide Synthase in a Mouse Model of Escherichia coli Lipopolysaccharide-Induced Bladder Inflammation
    Walter S. Kang, Frank J. Tamarkin, Marcia A. Wheeler and Robert M. Weiss
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 452-458; DOI: https://doi.org/10.1124/jpet.104.066506
  • You have access
    Role of Adenosine A1 Receptor in the Regulation of Gastrin Release
    Linda Yip, Henry Chi Hang Leung and Yin Nam Kwok
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 477-487; DOI: https://doi.org/10.1124/jpet.104.066654
  • You have access
    Disruption of the Ah Receptor Gene Alters the Susceptibility of Mice to Oxygen-Mediated Regulation of Pulmonary and Hepatic Cytochromes P4501A Expression and Exacerbates Hyperoxic Lung Injury
    Weiwu Jiang, Stephen E. Welty, Xanthi I. Couroucli, Roberto Barrios, Sudha R. Kondraganti, Kathirvel Muthiah, Ling Yu, Stephen E. Avery and Bhagavatula Moorthy
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 512-519; DOI: https://doi.org/10.1124/jpet.103.059766
  • You have access
    A c-Jun NH2-Terminal Kinase Inhibitor SP600125 (Anthra[1,9-cd]pyrazole-6 (2H)-one) Blocks Activation of Pancreatic Stellate Cells
    Atsushi Masamune, Kazuhiro Kikuta, Noriaki Suzuki, Masahiro Satoh, Kennichi Satoh and Tooru Shimosegawa
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 520-527; DOI: https://doi.org/10.1124/jpet.104.067280
  • You have access
    Induction of Small Intestinal Damage in Rats Following Combined Treatment with Cyclooxygenase-2 and Nitric-Oxide Synthase Inhibitors
    Ryoko Ohno, Aya Yokota, Akiko Tanaka and Koji Takeuchi
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 821-827; DOI: https://doi.org/10.1124/jpet.104.065961

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    Cyclooxygenases 1, 2, and 3 and the Production of Prostaglandin I2: Investigating the Activities of Acetaminophen and Cyclooxygenase-2-Selective Inhibitors in Rat Tissues
    Timothy D. Warner, Ivana Vojnovic, Francesco Giuliano, Rosario Jiménez, David Bishop-Bailey and Jane A. Mitchell
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 642-647; DOI: https://doi.org/10.1124/jpet.103.063875
  • You have access
    Interleukin-18 Induces Mechanical Hypernociception in Rats via Endothelin Acting on ETB Receptors in a Morphine-Sensitive Manner
    Waldiceu A. Verri, Ieda R. S. Schivo, Thiago M. Cunha, Foo Y. Liew, Sergio H. Ferreira and Fernando Q. Cunha
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 710-717; DOI: https://doi.org/10.1124/jpet.103.063990
  • You have access
    Preferential Inhibition of T Helper 1, but Not T Helper 2, Cytokines in Vitro by L-826,141 [4-{2-(3,4-Bisdifluromethoxyphenyl)-2-{4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl}-3-methylpyridine-1-oxide], a Potent and Selective Phosphodiesterase 4 Inhibitor
    D. Claveau, S. L. Chen, S. O'Keefe, D. M. Zaller, A. Styhler, S. Liu, Z. Huang, D. W. Nicholson and J. A. Mancini
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 752-760; DOI: https://doi.org/10.1124/jpet.103.064691

NEUROPHARMACOLOGY

  • You have access
    A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia
    Akinori Iwashita, Nobuteru Tojo, Shigeru Matsuura, Syunji Yamazaki, Kazunori Kamijo, Junya Ishida, Hirofumi Yamamoto, Kouji Hattori, Nobuya Matsuoka and Seitaro Mutoh
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 425-436; DOI: https://doi.org/10.1124/jpet.104.066944
  • You have access
    Regulation of Blood-Brain Barrier Na,K,2Cl-Cotransporter through Phosphorylation during in Vitro Stroke Conditions and Nicotine Exposure
    Thomas J. Abbruscato, Steve P. Lopez, Karen Roder and Jennifer R. Paulson
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 459-468; DOI: https://doi.org/10.1124/jpet.104.066274
  • You have access
    Differential Activity of the Nerve Growth Factor (NGF) Antagonist PD90780 [7-(Benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic Acid] Suggests Altered NGF-p75NTR Interactions in the Presence of TrkA
    Amy Colquhoun, Gail M. Lawrance, Igor L. Shamovsky, Richard J. Riopelle and Gregory M. Ross
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 505-511; DOI: https://doi.org/10.1124/jpet.104.066225
  • You have access
    Characterization of Two Novel N-Methyl-D-aspartate Antagonists: EAA-090 (2-[8,9-Dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic Acid) and EAB-318 (R-α-Amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic Acid Hydrochloride)
    Lucy Sun, Doreen Chiu, Dianne Kowal, Rachelle Simon, Michelle Smeyne, R. Suzanne Zukin, John Olney, Reinhardt Baudy and Stephen Lin
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 563-570; DOI: https://doi.org/10.1124/jpet.104.066092
  • You have access
    Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe Nucleus
    Jordanna E. Bermack, Nasser Haddjeri and Guy Debonnel
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 578-583; DOI: https://doi.org/10.1124/jpet.104.066472
  • You have access
    3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects
    Jean De Vry, Dirk Denzer, Elke Reissmueller, Maud Eijckenboom, Markus Heil, Heinrich Meier and Frank Mauler
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 620-632; DOI: https://doi.org/10.1124/jpet.103.062836
  • You have access
    A Guinea Pig Hippocampal Slice Model of Organophosphate-Induced Seizure Activity
    Patrick K. Harrison, Robert D. Sheridan, A. Chris Green, Iain R. Scott and John E. H. Tattersall
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 678-686; DOI: https://doi.org/10.1124/jpet.104.065433
  • You have access
    Serotonin 5-HT2A Receptors Underlie Increased Motor Behaviors Induced in Dopamine-Depleted Rats by Intrastriatal 5-HT2A/2C Agonism
    Christopher Bishop, Jennifer L. Tessmer, Thomas Ullrich, Kenner C. Rice and Paul D. Walker
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 687-694; DOI: https://doi.org/10.1124/jpet.104.066365
  • You have access
    Behavior of α-, β-, and γ-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier
    V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli and E. Monflier
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 745-751; DOI: https://doi.org/10.1124/jpet.104.067512
  • You have access
    In Vivo Regulation of Extracellular Signal-Regulated Protein Kinase (ERK) and Protein Kinase B (Akt) Phosphorylation by Acute and Chronic Morphine
    Daniella L. Muller and Ellen M. Unterwald
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 774-782; DOI: https://doi.org/10.1124/jpet.104.066548
  • You have access
    DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: I. In Vitro Pharmacological Characterization and Pharmacokinetic Properties
    Kenneth J. Valenzano, Wendy Miller, Zhengming Chen, Shen Shan, Gregg Crumley, Sam F. Victory, Ellen Davies, Jin-Cheng Huang, Nezima Allie, Scott J. Nolan, Yakov Rotshteyn, Donald J. Kyle and Kevin Broglé
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 783-792; DOI: https://doi.org/10.1124/jpet.103.063313
  • You have access
    DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: II. In Vivo Pharmacological Characterization in the Rat
    Garth T. Whiteside, James E. Harrison, Michelle S. Pearson, Zhengming Chen, Yakov Rotshteyn, Paul I. Turchin, James D. Pomonis, Lilly Mark, Katharine Walker and Kevin C. Broglé
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 793-799; DOI: https://doi.org/10.1124/jpet.103.063560
  • You have access
    Inorganic Lead Exposure in the Rat Activates Striatal cFOS Expression at Lower Blood Levels and Inhibits Amphetamine-Induced cFOS Expression at Higher Blood Levels
    Mark W. Lewis and David K. Pitts
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 815-820; DOI: https://doi.org/10.1124/jpet.103.063941
  • You have access
    A Pulmonary Formulation of l-Dopa Enhances Its Effectiveness in a Rat Model of Parkinson's Disease
    Raymond T. Bartus, Dwaine Emerich, Pam Snodgrass-Belt, Karen Fu, Heather Salzberg-Brenhouse, Denise Lafreniere, Leah Novak, Ee-Sing Lo, Thomas Cooper and Anthony S. Basile
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 828-835; DOI: https://doi.org/10.1124/jpet.103.064121

TOXICOLOGY

  • You have access
    Site-Specific Metabolism of Naphthalene and 1-Nitronaphthalene in Dissected Airways of Rhesus Macaques
    Bridget Boland, Ching Yu Lin, Dexter Morin, Lisa Miller, Charles Plopper and Alan Buckpitt
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 546-554; DOI: https://doi.org/10.1124/jpet.103.063669
  • You have access
    Structural Features of the Botulinum Neurotoxin Molecule That Govern Binding and Transcytosis across Polarized Human Intestinal Epithelial Cells
    Andrew B. Maksymowych and Lance L. Simpson
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 633-641; DOI: https://doi.org/10.1124/jpet.104.066845

Errata

  • You have access
    Correction to “Effects of Alcohols and Anesthetics on Recombinant Voltage-Gated Na+ Channels”
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 843;
  • You have access
    Correction to “Pharmacokinetics and Biodistribution of the Antitumor Immunoconjugate, Cantuzumab Mertansine (huC242-DM1), and Its Two Components in Mice”
    Journal of Pharmacology and Experimental Therapeutics August 2004, 310 (2) 844;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 2
1 Aug 2004
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • ENDOCRINE AND REPRODUCTIVE
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Errata
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • Stem Cells Therapies in AD
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics